Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Influenza A(H1N1)pdm09 and cystic fibrosis lung disease: a systematic meta-analysis.

Renk H, Regamey N, Hartl D.

PLoS One. 2014 Jan 10;9(1):e78583. doi: 10.1371/journal.pone.0078583. Erratum in: PLoS One. 2014;9(3):e93142.

2.

Lessons from a French collaborative case-control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy.

Bucher J, Boelle PY, Hubert D, Lebourgeois M, Stremler N, Durieu I, Bremont F, Deneuville E, Delaisi B, Corvol H, Bassinet L, Grenet D, Remus N, Vodoff MV, Boussaud V, Troussier F, Leruez-Ville M, Treluyer JM, Launay O, Sermet-Gaudelus I.

BMC Infect Dis. 2016 Feb 1;16:55. doi: 10.1186/s12879-016-1352-2.

3.

Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis.

Viviani L, Assael BM, Kerem E; ECFS (A) H1N1 study group..

J Cyst Fibros. 2011 Sep;10(5):370-6. doi: 10.1016/j.jcf.2011.06.004.

4.

Incidence and epidemiology of hospitalized influenza cases in rural Thailand during the influenza A (H1N1)pdm09 pandemic, 2009-2010.

Baggett HC, Chittaganpitch M, Thamthitiwat S, Prapasiri P, Naorat S, Sawatwong P, Ditsungnoen D, Olsen SJ, Simmerman JM, Srisaengchai P, Chantra S, Peruski LF, Sawanpanyalert P, Maloney SA, Akarasewi P.

PLoS One. 2012;7(11):e48609. doi: 10.1371/journal.pone.0048609.

5.

Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B.

Kawai N, Ikematsu H, Kawashima T, Maeda T, Ukai H, Hirotsu N, Iwaki N, Kashiwagi S.

Influenza Other Respir Viruses. 2013 May;7(3):448-55. doi: 10.1111/j.1750-2659.2012.00421.x.

6.

The month of July: an early experience with pandemic influenza A (H1N1) in adults with cystic fibrosis.

France MW, Tai S, Masel PJ, Moore VL, McMahon TL, Ritchie AJ, Bell SC.

BMC Pulm Med. 2010 Feb 25;10:8. doi: 10.1186/1471-2466-10-8.

7.

A prospective comparison of the epidemiological and clinical characteristics of pandemic (H1N1) 2009 influenza A virus and seasonal influenza A viruses in Guangzhou, South China in 2009.

Yang ZF, Zhan YQ, Chen RC, Zhou R, Wang YT, Luo Y, Jiang M, Li JQ, Qin S, Guan WD, Lai KF, Wen HL, Liang ZW, Li L, Zhong NS.

Jpn J Infect Dis. 2012;65(3):208-14.

8.

Hospitalizations from pandemic Influenza [A(H1N1)pdm09] infections among type 1 and 2 diabetes patients in Spain.

Jiménez-García R, Hernández-Barrera V, Rodríguez-Rieiro C, Lopez de Andres A, de Miguel-Diez J, Jimenez-Trujillo I, Gil de Miguel A, Carrasco-Garrido P.

Influenza Other Respir Viruses. 2013 May;7(3):439-47. doi: 10.1111/j.1750-2659.2012.00419.x.

9.

A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates.

Hansen C, Desai S, Bredfeldt C, Cheetham C, Gallagher M, Li DK, Raebel MA, Riedlinger K, Shay DK, Thompson M, Davis RL.

J Infect Dis. 2012 Oct;206(8):1260-8.

PMID:
22859826
10.

Macrophage activation syndrome induced by A/H1N1 influenza in cystic fibrosis.

Casciaro R, Cresta F, Favilli F, Naselli A, De Alessandri A, Minicucci L.

Pediatr Pulmonol. 2014 Feb;49(2):E10-2. doi: 10.1002/ppul.22778.

PMID:
23401277
11.

Influenza A(H1N1)pdm09-related pneumonia and other complications.

Viasus D, Oteo Revuelta JA, Martínez-Montauti J, Carratalà J.

Enferm Infecc Microbiol Clin. 2012 Oct;30 Suppl 4:43-8. doi: 10.1016/S0213-005X(12)70104-0. Review.

PMID:
23116792
12.

2009 Pandemic influenza A virus subtype H1N1 in Morocco, 2009-2010: epidemiology, transmissibility, and factors associated with fatal cases.

Barakat A, Ihazmad H, El Falaki F, Tempia S, Cherkaoui I, El Aouad R.

J Infect Dis. 2012 Dec 15;206 Suppl 1:S94-100. doi: 10.1093/infdis/jis547.

13.

Mortality, severe acute respiratory infection, and influenza-like illness associated with influenza A(H1N1)pdm09 in Argentina, 2009.

Azziz-Baumgartner E, Cabrera AM, Chang L, Calli R, Kusznierz G, Baez C, Yedlin P, Zamora AM, Cuezzo R, Sarrouf EB, Uboldi A, Herrmann J, Zerbini E, Uez O, Rico Cordeiro PO, Chavez P, Han G, Antman J, Coronado F, Bresee J, Kosacoff M, Widdowson MA, Echenique H.

PLoS One. 2012;7(10):e47540. doi: 10.1371/journal.pone.0047540.

14.

Predictors of influenza in the adult population during seasonal and A(H1N1)pdm09 pandemic influenza periods.

Gefenaite G, Tacken M, Kolthof J, Mulder B, Korevaar JC, Stirbu-Wagner I, Bos J, Stolk RP, Hak E.

Epidemiol Infect. 2014 May;142(5):950-4. doi: 10.1017/S0950268813002434.

PMID:
24073672
15.

Acute severe deterioration in cystic fibrosis associated with influenza A virus infection.

Conway SP, Simmonds EJ, Littlewood JM.

Thorax. 1992 Feb;47(2):112-4.

16.

Analysis of the influenza A (H1N1) 2009 pandemic infection in Japanese asthmatic patients: using a questionnaire-based survey.

Koshio N, Hasegawa T, Suzuki K, Tanabe Y, Koya T, Sakagami T, Aoki N, Hoshino Y, Kagamu H, Tsukada H, Arakawa M, Gejyo F, Narita I, Suzuki E; Niigata Asthma Treatment Study Group..

Allergol Int. 2014 Mar;63(1):67-74. doi: 10.2332/allergolint.13-OA-0609.

17.

Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.

Njuguna H, Ahmed J, Oria PA, Arunga G, Williamson J, Kosgey A, Muthoka P, Mott JA, Breiman RF, Katz MA.

Vaccine. 2013 Sep 23;31(41):4662-7. doi: 10.1016/j.vaccine.2013.07.005.

PMID:
23859843
18.

Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria.

Poeppl W, Hell M, Herkner H, Stoiser B, Fritsche G, Schurz-Bamieh N, Poeppl G, Gattringer R, Jones N, Maass M, Egle A, Burgmann H.

Infection. 2011 Aug;39(4):341-52. doi: 10.1007/s15010-011-0121-9.

PMID:
21544585
19.

Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses.

Yin JK, Chow MY, Khandaker G, King C, Richmond P, Heron L, Booy R.

Vaccine. 2012 May 2;30(21):3209-22. doi: 10.1016/j.vaccine.2012.02.048. Review.

PMID:
22387221
20.

Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.

Bateman AC, Kieke BA, Irving SA, Meece JK, Shay DK, Belongia EA.

J Infect Dis. 2013 Apr 15;207(8):1262-9. doi: 10.1093/infdis/jit020.

PMID:
23341536

Supplemental Content

Support Center